Overview
China aesthetic treatment platform's Q4 revenue grew 25% yr/yr, driven by branded center expansion
Q4 net loss narrowed sharply from prior yr, but non-GAAP net loss increased
Company extended share repurchase program through March 2027, repurchased 4.8 mln ADSs
Outlook
So-Young expects Q1 2026 aesthetic treatment services revenue of RMB268 mln to RMB278 mln
Company says outlook reflects current market conditions and preliminary estimates of customer demand
So-Young plans steady store expansion and prioritizes operational excellence in 2026
Result Drivers
AESTHETIC CENTER EXPANSION - Revenue growth in Q4 was primarily driven by business expansion of branded aesthetic centers
DECLINE IN PLATFORM SERVICES - Revenues from information and reservation services and medical products fell due to fewer medical service providers subscribing and lower equipment sales
HIGHER SALES AND MARKETING SPEND - Increased sales and marketing expenses were mainly due to branding and user acquisition activities for the branded aesthetic centers
Company press release: ID:nPn2zc0y8a
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| RMB 460.72 mln |
|
Q4 Net Income |
| -RMB 114.12 mln |
|
Q4 Gross Profit |
| RMB 204.77 mln |
|
Q4 Income from Operations |
| -RMB 122.94 mln |
|
Q4 Operating Expenses |
| -RMB 327.72 mln |
|
Q4 Pretax Profit |
| -RMB 114.73 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the online services peer group is "buy."
Wall Street's median 12-month price target for So-Young International Inc is $7.60, about 161.2% above its March 24 closing price of $2.91
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.